Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India: GlobalData Read more
Jenburkt Pharmaceuticals second in India to launch Favipiravir (FaviventTM) to fight COVID-19 Read more
Glenmark announces top-line results from Phase 3 clinical trial of favipiravir for COVID-19 treatment Read more